Reply to M. Di Maio and F. Perrone.

[1]  M. Di Maio,et al.  Subgroup Analysis: Refining a Positive Result or Trying to Rescue a Negative One? , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  S. Zhang,et al.  Subgroup Analyses in Reporting of Phase III Clinical Trials in Solid Tumors. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  Thomas Agoritsas,et al.  How to use a subgroup analysis: users' guide to the medical literature. , 2014, JAMA.

[4]  Gordon H Guyatt,et al.  Credibility of claims of subgroup effects in randomised controlled trials: systematic review , 2012, BMJ : British Medical Journal.

[5]  G. Guyatt,et al.  The influence of study characteristics on reporting of subgroup analyses in randomised controlled trials: systematic review , 2011, BMJ : British Medical Journal.

[6]  Stephen W Lagakos,et al.  Statistics in medicine--reporting of subgroup analyses in clinical trials. , 2007, The New England journal of medicine.